LDLR and atherosclerosis: However, when the mutant LDLRE208X strain was treated with AAV-CRISPR-Cas9, LDLR expression was partially restored, and the signs of atherosclerosis were mitigated, highlighting the potential use of CRISPR-Cas9 in the treatment of the HoFH [99].